003220 — Daewon Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩320bn
- KR₩434bn
- KR₩527bn
- 68
- 67
- 46
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 26,879 | 17,198 | 6,611 | 30,657 | 23,463 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 18,928 | 16,515 | 23,703 | 24,937 | 20,532 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -26,651 | -24,435 | -23,813 | -48,549 | -9,822 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 30,971 | 24,951 | 24,307 | 26,413 | 51,734 |
Capital Expenditures | -36,652 | -15,784 | -11,707 | -13,365 | -20,611 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -11,030 | 891 | -29,908 | -7,410 | -47,656 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -47,682 | -14,893 | -41,615 | -20,775 | -68,267 |
Financing Cash Flow Items | -1,150 | -1,260 | -1,906 | -3,241 | -4,434 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14,824 | -12,584 | 48,527 | -20,411 | 19,513 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,884 | -2,565 | 31,258 | -14,727 | 3,013 |